nodes	percent_of_prediction	percent_of_DWPC	metapath
Oritavancin—Mediastinal disorder—Apraclonidine—glaucoma	0.00498	0.00498	CcSEcCtD
Oritavancin—Infestation NOS—Brinzolamide—glaucoma	0.00496	0.00496	CcSEcCtD
Oritavancin—Infestation—Brinzolamide—glaucoma	0.00496	0.00496	CcSEcCtD
Oritavancin—Mediastinal disorder—Bimatoprost—glaucoma	0.00483	0.00483	CcSEcCtD
Oritavancin—Nervous system disorder—Latanoprost—glaucoma	0.00482	0.00482	CcSEcCtD
Oritavancin—Skin disorder—Latanoprost—glaucoma	0.00477	0.00477	CcSEcCtD
Oritavancin—Gastrointestinal disorder—Diclofenamide—glaucoma	0.00476	0.00476	CcSEcCtD
Oritavancin—Erythema multiforme—Acetazolamide—glaucoma	0.00467	0.00467	CcSEcCtD
Oritavancin—Musculoskeletal discomfort—Latanoprost—glaucoma	0.00447	0.00447	CcSEcCtD
Oritavancin—Hypersensitivity—Metipranolol—glaucoma	0.00446	0.00446	CcSEcCtD
Oritavancin—Connective tissue disorder—Travoprost—glaucoma	0.00443	0.00443	CcSEcCtD
Oritavancin—Hypoglycaemia—Betaxolol—glaucoma	0.00441	0.00441	CcSEcCtD
Oritavancin—Cardiac disorder—Brimonidine—glaucoma	0.0044	0.0044	CcSEcCtD
Oritavancin—Oedema peripheral—Brinzolamide—glaucoma	0.00439	0.00439	CcSEcCtD
Oritavancin—Gastrointestinal disorder—Methazolamide—glaucoma	0.00438	0.00438	CcSEcCtD
Oritavancin—Connective tissue disorder—Brinzolamide—glaucoma	0.00438	0.00438	CcSEcCtD
Oritavancin—Immune system disorder—Brimonidine—glaucoma	0.00428	0.00428	CcSEcCtD
Oritavancin—Erythema multiforme—Dorzolamide—glaucoma	0.00428	0.00428	CcSEcCtD
Oritavancin—Mediastinal disorder—Brimonidine—glaucoma	0.00427	0.00427	CcSEcCtD
Oritavancin—Oedema peripheral—Pilocarpine—glaucoma	0.00422	0.00422	CcSEcCtD
Oritavancin—Urticaria—Levobunolol—glaucoma	0.00421	0.00421	CcSEcCtD
Oritavancin—Cardiac disorder—Travoprost—glaucoma	0.00419	0.00419	CcSEcCtD
Oritavancin—Cardiac disorder—Brinzolamide—glaucoma	0.00413	0.00413	CcSEcCtD
Oritavancin—Hypersensitivity—Carteolol—glaucoma	0.00413	0.00413	CcSEcCtD
Oritavancin—Myalgia—Apraclonidine—glaucoma	0.00409	0.00409	CcSEcCtD
Oritavancin—Immune system disorder—Travoprost—glaucoma	0.00407	0.00407	CcSEcCtD
Oritavancin—Unspecified disorder of skin and subcutaneous tissue—Apraclonidine—glaucoma	0.00407	0.00407	CcSEcCtD
Oritavancin—Mediastinal disorder—Travoprost—glaucoma	0.00406	0.00406	CcSEcCtD
Oritavancin—Urticaria—Methazolamide—glaucoma	0.00403	0.00403	CcSEcCtD
Oritavancin—Immune system disorder—Brinzolamide—glaucoma	0.00402	0.00402	CcSEcCtD
Oritavancin—Mediastinal disorder—Brinzolamide—glaucoma	0.00401	0.00401	CcSEcCtD
Oritavancin—Dizziness—Metipranolol—glaucoma	0.004	0.004	CcSEcCtD
Oritavancin—Unspecified disorder of skin and subcutaneous tissue—Bimatoprost—glaucoma	0.00394	0.00394	CcSEcCtD
Oritavancin—Hypersensitivity—Levobunolol—glaucoma	0.0039	0.0039	CcSEcCtD
Oritavancin—Infection—Apraclonidine—glaucoma	0.0039	0.0039	CcSEcCtD
Oritavancin—Pruritus—Diclofenamide—glaucoma	0.0039	0.0039	CcSEcCtD
Oritavancin—Malnutrition—Brinzolamide—glaucoma	0.00388	0.00388	CcSEcCtD
Oritavancin—Aspartate aminotransferase increased—Betaxolol—glaucoma	0.00387	0.00387	CcSEcCtD
Oritavancin—Nervous system disorder—Apraclonidine—glaucoma	0.00385	0.00385	CcSEcCtD
Oritavancin—Rash—Metipranolol—glaucoma	0.00381	0.00381	CcSEcCtD
Oritavancin—Skin disorder—Apraclonidine—glaucoma	0.00381	0.00381	CcSEcCtD
Oritavancin—Dermatitis—Metipranolol—glaucoma	0.00381	0.00381	CcSEcCtD
Oritavancin—Alanine aminotransferase increased—Betaxolol—glaucoma	0.00379	0.00379	CcSEcCtD
Oritavancin—Headache—Metipranolol—glaucoma	0.00379	0.00379	CcSEcCtD
Oritavancin—Infection—Bimatoprost—glaucoma	0.00378	0.00378	CcSEcCtD
Oritavancin—Pruritus—Levobunolol—glaucoma	0.00375	0.00375	CcSEcCtD
Oritavancin—Nervous system disorder—Bimatoprost—glaucoma	0.00373	0.00373	CcSEcCtD
Oritavancin—Dizziness—Carteolol—glaucoma	0.00371	0.00371	CcSEcCtD
Oritavancin—Skin disorder—Bimatoprost—glaucoma	0.0037	0.0037	CcSEcCtD
Oritavancin—Diarrhoea—Carbachol—glaucoma	0.00368	0.00368	CcSEcCtD
Oritavancin—Bronchospasm—Betaxolol—glaucoma	0.00366	0.00366	CcSEcCtD
Oritavancin—Dizziness—Diclofenamide—glaucoma	0.00364	0.00364	CcSEcCtD
Oritavancin—Diarrhoea—Levobunolol—glaucoma	0.00362	0.00362	CcSEcCtD
Oritavancin—Angioedema—Dorzolamide—glaucoma	0.0036	0.0036	CcSEcCtD
Oritavancin—Hypoglycaemia—Timolol—glaucoma	0.0036	0.0036	CcSEcCtD
Oritavancin—Nausea—Metipranolol—glaucoma	0.00359	0.00359	CcSEcCtD
Oritavancin—Musculoskeletal discomfort—Apraclonidine—glaucoma	0.00358	0.00358	CcSEcCtD
Oritavancin—Dizziness—Carbachol—glaucoma	0.00356	0.00356	CcSEcCtD
Oritavancin—Myalgia—Brimonidine—glaucoma	0.00352	0.00352	CcSEcCtD
Oritavancin—Headache—Carteolol—glaucoma	0.00351	0.00351	CcSEcCtD
Oritavancin—Vomiting—Diclofenamide—glaucoma	0.0035	0.0035	CcSEcCtD
Oritavancin—Dizziness—Levobunolol—glaucoma	0.0035	0.0035	CcSEcCtD
Oritavancin—Unspecified disorder of skin and subcutaneous tissue—Brimonidine—glaucoma	0.00349	0.00349	CcSEcCtD
Oritavancin—Pruritus—Latanoprost—glaucoma	0.00347	0.00347	CcSEcCtD
Oritavancin—Rash—Diclofenamide—glaucoma	0.00347	0.00347	CcSEcCtD
Oritavancin—Diarrhoea—Methazolamide—glaucoma	0.00347	0.00347	CcSEcCtD
Oritavancin—Headache—Diclofenamide—glaucoma	0.00345	0.00345	CcSEcCtD
Oritavancin—Vomiting—Carbachol—glaucoma	0.00342	0.00342	CcSEcCtD
Oritavancin—Rash—Carbachol—glaucoma	0.00339	0.00339	CcSEcCtD
Oritavancin—Gastrointestinal disorder—Apraclonidine—glaucoma	0.00339	0.00339	CcSEcCtD
Oritavancin—Dermatitis—Carbachol—glaucoma	0.00339	0.00339	CcSEcCtD
Oritavancin—Headache—Carbachol—glaucoma	0.00337	0.00337	CcSEcCtD
Oritavancin—Infection—Brimonidine—glaucoma	0.00335	0.00335	CcSEcCtD
Oritavancin—Myalgia—Travoprost—glaucoma	0.00334	0.00334	CcSEcCtD
Oritavancin—Nausea—Carteolol—glaucoma	0.00333	0.00333	CcSEcCtD
Oritavancin—Unspecified disorder of skin and subcutaneous tissue—Travoprost—glaucoma	0.00332	0.00332	CcSEcCtD
Oritavancin—Headache—Levobunolol—glaucoma	0.00332	0.00332	CcSEcCtD
Oritavancin—Infestation NOS—Betaxolol—glaucoma	0.00332	0.00332	CcSEcCtD
Oritavancin—Infestation—Betaxolol—glaucoma	0.00332	0.00332	CcSEcCtD
Oritavancin—Nervous system disorder—Brimonidine—glaucoma	0.0033	0.0033	CcSEcCtD
Oritavancin—Myalgia—Brinzolamide—glaucoma	0.0033	0.0033	CcSEcCtD
Oritavancin—Tachycardia—Brimonidine—glaucoma	0.00329	0.00329	CcSEcCtD
Oritavancin—Gastrointestinal disorder—Bimatoprost—glaucoma	0.00329	0.00329	CcSEcCtD
Oritavancin—Unspecified disorder of skin and subcutaneous tissue—Brinzolamide—glaucoma	0.00328	0.00328	CcSEcCtD
Oritavancin—Skin disorder—Brimonidine—glaucoma	0.00327	0.00327	CcSEcCtD
Oritavancin—Nausea—Diclofenamide—glaucoma	0.00327	0.00327	CcSEcCtD
Oritavancin—Dizziness—Latanoprost—glaucoma	0.00325	0.00325	CcSEcCtD
Oritavancin—Vomiting—Methazolamide—glaucoma	0.00323	0.00323	CcSEcCtD
Oritavancin—Rash—Methazolamide—glaucoma	0.0032	0.0032	CcSEcCtD
Oritavancin—Dermatitis—Methazolamide—glaucoma	0.0032	0.0032	CcSEcCtD
Oritavancin—Nausea—Carbachol—glaucoma	0.00319	0.00319	CcSEcCtD
Oritavancin—Infection—Travoprost—glaucoma	0.00318	0.00318	CcSEcCtD
Oritavancin—Headache—Methazolamide—glaucoma	0.00318	0.00318	CcSEcCtD
Oritavancin—Cardiac disorder—Clonidine—glaucoma	0.00317	0.00317	CcSEcCtD
Oritavancin—Myalgia—Pilocarpine—glaucoma	0.00317	0.00317	CcSEcCtD
Oritavancin—Nausea—Levobunolol—glaucoma	0.00315	0.00315	CcSEcCtD
Oritavancin—Infection—Brinzolamide—glaucoma	0.00314	0.00314	CcSEcCtD
Oritavancin—Nervous system disorder—Travoprost—glaucoma	0.00314	0.00314	CcSEcCtD
Oritavancin—Tachycardia—Travoprost—glaucoma	0.00313	0.00313	CcSEcCtD
Oritavancin—Skin disorder—Travoprost—glaucoma	0.00311	0.00311	CcSEcCtD
Oritavancin—Nervous system disorder—Brinzolamide—glaucoma	0.0031	0.0031	CcSEcCtD
Oritavancin—Rash—Latanoprost—glaucoma	0.0031	0.0031	CcSEcCtD
Oritavancin—Dermatitis—Latanoprost—glaucoma	0.00309	0.00309	CcSEcCtD
Oritavancin—Tachycardia—Brinzolamide—glaucoma	0.00309	0.00309	CcSEcCtD
Oritavancin—Mediastinal disorder—Clonidine—glaucoma	0.00308	0.00308	CcSEcCtD
Oritavancin—Headache—Latanoprost—glaucoma	0.00308	0.00308	CcSEcCtD
Oritavancin—Skin disorder—Brinzolamide—glaucoma	0.00307	0.00307	CcSEcCtD
Oritavancin—Musculoskeletal discomfort—Brimonidine—glaucoma	0.00307	0.00307	CcSEcCtD
Oritavancin—Gastrointestinal disorder—Acetazolamide—glaucoma	0.00303	0.00303	CcSEcCtD
Oritavancin—Infection—Pilocarpine—glaucoma	0.00302	0.00302	CcSEcCtD
Oritavancin—Nausea—Methazolamide—glaucoma	0.00301	0.00301	CcSEcCtD
Oritavancin—Bronchospasm—Timolol—glaucoma	0.00299	0.00299	CcSEcCtD
Oritavancin—Tachycardia—Pilocarpine—glaucoma	0.00297	0.00297	CcSEcCtD
Oritavancin—Musculoskeletal discomfort—Dorzolamide—glaucoma	0.00293	0.00293	CcSEcCtD
Oritavancin—Musculoskeletal discomfort—Travoprost—glaucoma	0.00292	0.00292	CcSEcCtD
Oritavancin—Gastrointestinal disorder—Brimonidine—glaucoma	0.00291	0.00291	CcSEcCtD
Oritavancin—Hypersensitivity—Apraclonidine—glaucoma	0.00289	0.00289	CcSEcCtD
Oritavancin—Musculoskeletal discomfort—Brinzolamide—glaucoma	0.00288	0.00288	CcSEcCtD
Oritavancin—Urticaria—Acetazolamide—glaucoma	0.00279	0.00279	CcSEcCtD
Oritavancin—Pruritus—Apraclonidine—glaucoma	0.00278	0.00278	CcSEcCtD
Oritavancin—Musculoskeletal discomfort—Pilocarpine—glaucoma	0.00277	0.00277	CcSEcCtD
Oritavancin—Gastrointestinal disorder—Travoprost—glaucoma	0.00277	0.00277	CcSEcCtD
Oritavancin—Cardiac disorder—Betaxolol—glaucoma	0.00276	0.00276	CcSEcCtD
Oritavancin—Gastrointestinal disorder—Brinzolamide—glaucoma	0.00273	0.00273	CcSEcCtD
Oritavancin—Angioedema—Clonidine—glaucoma	0.00272	0.00272	CcSEcCtD
Oritavancin—Pruritus—Bimatoprost—glaucoma	0.00269	0.00269	CcSEcCtD
Oritavancin—Immune system disorder—Betaxolol—glaucoma	0.00269	0.00269	CcSEcCtD
Oritavancin—Diarrhoea—Apraclonidine—glaucoma	0.00269	0.00269	CcSEcCtD
Oritavancin—Mediastinal disorder—Betaxolol—glaucoma	0.00268	0.00268	CcSEcCtD
Oritavancin—Gastrointestinal disorder—Pilocarpine—glaucoma	0.00263	0.00263	CcSEcCtD
Oritavancin—Dizziness—Apraclonidine—glaucoma	0.0026	0.0026	CcSEcCtD
Oritavancin—Malnutrition—Betaxolol—glaucoma	0.00259	0.00259	CcSEcCtD
Oritavancin—Urticaria—Dorzolamide—glaucoma	0.00256	0.00256	CcSEcCtD
Oritavancin—Dizziness—Bimatoprost—glaucoma	0.00252	0.00252	CcSEcCtD
Oritavancin—Unspecified disorder of skin and subcutaneous tissue—Clonidine—glaucoma	0.00252	0.00252	CcSEcCtD
Oritavancin—Urticaria—Brinzolamide—glaucoma	0.00251	0.00251	CcSEcCtD
Oritavancin—Vomiting—Apraclonidine—glaucoma	0.0025	0.0025	CcSEcCtD
Oritavancin—Hypersensitivity—Brimonidine—glaucoma	0.00248	0.00248	CcSEcCtD
Oritavancin—Dermatitis—Apraclonidine—glaucoma	0.00247	0.00247	CcSEcCtD
Oritavancin—Headache—Apraclonidine—glaucoma	0.00246	0.00246	CcSEcCtD
Oritavancin—Infection—Clonidine—glaucoma	0.00241	0.00241	CcSEcCtD
Oritavancin—Diarrhoea—Acetazolamide—glaucoma	0.0024	0.0024	CcSEcCtD
Oritavancin—Rash—Bimatoprost—glaucoma	0.0024	0.0024	CcSEcCtD
Oritavancin—Dermatitis—Bimatoprost—glaucoma	0.0024	0.0024	CcSEcCtD
Oritavancin—Oedema peripheral—Timolol—glaucoma	0.00239	0.00239	CcSEcCtD
Oritavancin—Anaemia—Betaxolol—glaucoma	0.00239	0.00239	CcSEcCtD
Oritavancin—Connective tissue disorder—Timolol—glaucoma	0.00239	0.00239	CcSEcCtD
Oritavancin—Pruritus—Brimonidine—glaucoma	0.00238	0.00238	CcSEcCtD
Oritavancin—Headache—Bimatoprost—glaucoma	0.00238	0.00238	CcSEcCtD
Oritavancin—Nervous system disorder—Clonidine—glaucoma	0.00238	0.00238	CcSEcCtD
Oritavancin—Hypersensitivity—Dorzolamide—glaucoma	0.00237	0.00237	CcSEcCtD
Oritavancin—Tachycardia—Clonidine—glaucoma	0.00237	0.00237	CcSEcCtD
Oritavancin—Hypersensitivity—Travoprost—glaucoma	0.00236	0.00236	CcSEcCtD
Oritavancin—Skin disorder—Clonidine—glaucoma	0.00236	0.00236	CcSEcCtD
Oritavancin—Nausea—Apraclonidine—glaucoma	0.00233	0.00233	CcSEcCtD
Oritavancin—Hypersensitivity—Brinzolamide—glaucoma	0.00233	0.00233	CcSEcCtD
Oritavancin—Dizziness—Acetazolamide—glaucoma	0.00232	0.00232	CcSEcCtD
Oritavancin—Pruritus—Dorzolamide—glaucoma	0.00228	0.00228	CcSEcCtD
Oritavancin—Pruritus—Travoprost—glaucoma	0.00227	0.00227	CcSEcCtD
Oritavancin—Nausea—Bimatoprost—glaucoma	0.00226	0.00226	CcSEcCtD
Oritavancin—Cardiac disorder—Timolol—glaucoma	0.00226	0.00226	CcSEcCtD
Oritavancin—Hypersensitivity—Pilocarpine—glaucoma	0.00224	0.00224	CcSEcCtD
Oritavancin—Pruritus—Brinzolamide—glaucoma	0.00224	0.00224	CcSEcCtD
Oritavancin—Vomiting—Acetazolamide—glaucoma	0.00223	0.00223	CcSEcCtD
Oritavancin—Dizziness—Brimonidine—glaucoma	0.00223	0.00223	CcSEcCtD
Oritavancin—Musculoskeletal discomfort—Clonidine—glaucoma	0.00221	0.00221	CcSEcCtD
Oritavancin—Myalgia—Betaxolol—glaucoma	0.00221	0.00221	CcSEcCtD
Oritavancin—Diarrhoea—Dorzolamide—glaucoma	0.0022	0.0022	CcSEcCtD
Oritavancin—Headache—Acetazolamide—glaucoma	0.0022	0.0022	CcSEcCtD
Oritavancin—Immune system disorder—Timolol—glaucoma	0.0022	0.0022	CcSEcCtD
Oritavancin—Diarrhoea—Travoprost—glaucoma	0.00219	0.00219	CcSEcCtD
Oritavancin—Mediastinal disorder—Timolol—glaucoma	0.00219	0.00219	CcSEcCtD
Oritavancin—Unspecified disorder of skin and subcutaneous tissue—Betaxolol—glaucoma	0.00219	0.00219	CcSEcCtD
Oritavancin—Diarrhoea—Brinzolamide—glaucoma	0.00216	0.00216	CcSEcCtD
Oritavancin—Pruritus—Pilocarpine—glaucoma	0.00215	0.00215	CcSEcCtD
Oritavancin—Dizziness—Dorzolamide—glaucoma	0.00213	0.00213	CcSEcCtD
Oritavancin—Rash—Brimonidine—glaucoma	0.00212	0.00212	CcSEcCtD
Oritavancin—Dermatitis—Brimonidine—glaucoma	0.00212	0.00212	CcSEcCtD
Oritavancin—Dizziness—Travoprost—glaucoma	0.00212	0.00212	CcSEcCtD
Oritavancin—Malnutrition—Timolol—glaucoma	0.00212	0.00212	CcSEcCtD
Oritavancin—Headache—Brimonidine—glaucoma	0.00211	0.00211	CcSEcCtD
Oritavancin—Infection—Betaxolol—glaucoma	0.0021	0.0021	CcSEcCtD
Oritavancin—Gastrointestinal disorder—Clonidine—glaucoma	0.0021	0.0021	CcSEcCtD
Oritavancin—Dizziness—Brinzolamide—glaucoma	0.00209	0.00209	CcSEcCtD
Oritavancin—Nausea—Acetazolamide—glaucoma	0.00209	0.00209	CcSEcCtD
Oritavancin—Diarrhoea—Pilocarpine—glaucoma	0.00208	0.00208	CcSEcCtD
Oritavancin—Nervous system disorder—Betaxolol—glaucoma	0.00207	0.00207	CcSEcCtD
Oritavancin—Tachycardia—Betaxolol—glaucoma	0.00206	0.00206	CcSEcCtD
Oritavancin—Skin disorder—Betaxolol—glaucoma	0.00205	0.00205	CcSEcCtD
Oritavancin—Vomiting—Dorzolamide—glaucoma	0.00205	0.00205	CcSEcCtD
Oritavancin—Rash—Dorzolamide—glaucoma	0.00203	0.00203	CcSEcCtD
Oritavancin—Dermatitis—Dorzolamide—glaucoma	0.00203	0.00203	CcSEcCtD
Oritavancin—Rash—Travoprost—glaucoma	0.00202	0.00202	CcSEcCtD
Oritavancin—Dermatitis—Travoprost—glaucoma	0.00202	0.00202	CcSEcCtD
Oritavancin—Headache—Dorzolamide—glaucoma	0.00202	0.00202	CcSEcCtD
Oritavancin—Vomiting—Brinzolamide—glaucoma	0.00201	0.00201	CcSEcCtD
Oritavancin—Dizziness—Pilocarpine—glaucoma	0.00201	0.00201	CcSEcCtD
Oritavancin—Headache—Travoprost—glaucoma	0.00201	0.00201	CcSEcCtD
Oritavancin—Nausea—Brimonidine—glaucoma	0.002	0.002	CcSEcCtD
Oritavancin—Rash—Brinzolamide—glaucoma	0.00199	0.00199	CcSEcCtD
Oritavancin—Dermatitis—Brinzolamide—glaucoma	0.00199	0.00199	CcSEcCtD
Oritavancin—Headache—Brinzolamide—glaucoma	0.00198	0.00198	CcSEcCtD
Oritavancin—Angioedema—Timolol—glaucoma	0.00193	0.00193	CcSEcCtD
Oritavancin—Vomiting—Pilocarpine—glaucoma	0.00193	0.00193	CcSEcCtD
Oritavancin—Urticaria—Clonidine—glaucoma	0.00193	0.00193	CcSEcCtD
Oritavancin—Musculoskeletal discomfort—Betaxolol—glaucoma	0.00193	0.00193	CcSEcCtD
Oritavancin—Rash—Pilocarpine—glaucoma	0.00192	0.00192	CcSEcCtD
Oritavancin—Dermatitis—Pilocarpine—glaucoma	0.00192	0.00192	CcSEcCtD
Oritavancin—Nausea—Dorzolamide—glaucoma	0.00191	0.00191	CcSEcCtD
Oritavancin—Headache—Pilocarpine—glaucoma	0.00191	0.00191	CcSEcCtD
Oritavancin—Nausea—Travoprost—glaucoma	0.0019	0.0019	CcSEcCtD
Oritavancin—Nausea—Brinzolamide—glaucoma	0.00188	0.00188	CcSEcCtD
Oritavancin—Gastrointestinal disorder—Betaxolol—glaucoma	0.00183	0.00183	CcSEcCtD
Oritavancin—Nausea—Pilocarpine—glaucoma	0.00181	0.00181	CcSEcCtD
Oritavancin—Myalgia—Timolol—glaucoma	0.0018	0.0018	CcSEcCtD
Oritavancin—Unspecified disorder of skin and subcutaneous tissue—Timolol—glaucoma	0.00179	0.00179	CcSEcCtD
Oritavancin—Hypersensitivity—Clonidine—glaucoma	0.00179	0.00179	CcSEcCtD
Oritavancin—Pruritus—Clonidine—glaucoma	0.00172	0.00172	CcSEcCtD
Oritavancin—Infection—Timolol—glaucoma	0.00172	0.00172	CcSEcCtD
Oritavancin—Nervous system disorder—Timolol—glaucoma	0.00169	0.00169	CcSEcCtD
Oritavancin—Urticaria—Betaxolol—glaucoma	0.00168	0.00168	CcSEcCtD
Oritavancin—Skin disorder—Timolol—glaucoma	0.00168	0.00168	CcSEcCtD
Oritavancin—Diarrhoea—Clonidine—glaucoma	0.00166	0.00166	CcSEcCtD
Oritavancin—Dizziness—Clonidine—glaucoma	0.00161	0.00161	CcSEcCtD
Oritavancin—Musculoskeletal discomfort—Timolol—glaucoma	0.00157	0.00157	CcSEcCtD
Oritavancin—Hypersensitivity—Betaxolol—glaucoma	0.00156	0.00156	CcSEcCtD
Oritavancin—Vomiting—Clonidine—glaucoma	0.00154	0.00154	CcSEcCtD
Oritavancin—Rash—Clonidine—glaucoma	0.00153	0.00153	CcSEcCtD
Oritavancin—Dermatitis—Clonidine—glaucoma	0.00153	0.00153	CcSEcCtD
Oritavancin—Headache—Clonidine—glaucoma	0.00152	0.00152	CcSEcCtD
Oritavancin—Pruritus—Betaxolol—glaucoma	0.0015	0.0015	CcSEcCtD
Oritavancin—Gastrointestinal disorder—Timolol—glaucoma	0.00149	0.00149	CcSEcCtD
Oritavancin—Diarrhoea—Betaxolol—glaucoma	0.00145	0.00145	CcSEcCtD
Oritavancin—Nausea—Clonidine—glaucoma	0.00144	0.00144	CcSEcCtD
Oritavancin—Dizziness—Betaxolol—glaucoma	0.0014	0.0014	CcSEcCtD
Oritavancin—Urticaria—Timolol—glaucoma	0.00137	0.00137	CcSEcCtD
Oritavancin—Vomiting—Betaxolol—glaucoma	0.00134	0.00134	CcSEcCtD
Oritavancin—Rash—Betaxolol—glaucoma	0.00133	0.00133	CcSEcCtD
Oritavancin—Dermatitis—Betaxolol—glaucoma	0.00133	0.00133	CcSEcCtD
Oritavancin—Headache—Betaxolol—glaucoma	0.00132	0.00132	CcSEcCtD
Oritavancin—Hypersensitivity—Timolol—glaucoma	0.00127	0.00127	CcSEcCtD
Oritavancin—Nausea—Betaxolol—glaucoma	0.00126	0.00126	CcSEcCtD
Oritavancin—Pruritus—Timolol—glaucoma	0.00122	0.00122	CcSEcCtD
Oritavancin—Diarrhoea—Timolol—glaucoma	0.00118	0.00118	CcSEcCtD
Oritavancin—Dizziness—Timolol—glaucoma	0.00114	0.00114	CcSEcCtD
Oritavancin—Vomiting—Timolol—glaucoma	0.0011	0.0011	CcSEcCtD
Oritavancin—Rash—Timolol—glaucoma	0.00109	0.00109	CcSEcCtD
Oritavancin—Dermatitis—Timolol—glaucoma	0.00109	0.00109	CcSEcCtD
Oritavancin—Headache—Timolol—glaucoma	0.00108	0.00108	CcSEcCtD
Oritavancin—Nausea—Timolol—glaucoma	0.00103	0.00103	CcSEcCtD
